1.
Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-...
by Cahn, Pedro, Dr
The Lancet infectious diseases, 2014, Vol.14 (7), p.572-580
2.
Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial
by Molina, Jean-Michel, Dr, Prof
The Lancet (British edition), 2011, Vol.378 (9787), p.238-246
3.
Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial
by Madruga, José Valdez, Dr
The Lancet (British edition), 2007, Vol.370 (9581), p.29-38
Filter electronic articles 3 Hits
Remove Filters
- Middle Aged (3)
- Mutation (3)
- Hiv (3)
- Male (3)
- Female (3)
- Anti-Hiv Agents - Therapeutic Use (3)
- Aged
- Clinical Trials (3)
- Antiretroviral Drugs (3)
- Drug Therapy (2)
- Hiv Infections - Drug Therapy (2)
- Hiv-1 - Drug Effects (2)
- Double-Blind Method (2)
- Antibiotics. Antiinfectious Agen... (2)
- Anti-Hiv Agents - Adverse Effects (2)
- Antiviral Agents (2)
- Biological And Medical Sciences (2)
- less ...